Literature DB >> 21951283

3-O-methylfunicone, from Penicillium pinophilum, is a selective inhibitor of breast cancer stem cells.

E Buommino1, V Tirino, A De Filippis, F Silvestri, R Nicoletti, M L Ciavatta, G Pirozzi, M A Tufano.   

Abstract

OBJECTIVES: Cancer stem cells make up a subpopulation of cells within tumours that drive tumour initiation, growth and recurrence. They are resistant to many current types of cancer treatment, causing failure of such therapeutic approaches, including chemotherapy and radiotherapy. In the study described here, anti-proliferative effects of 3-O-methylfunicone (OMF), a metabolite from Penicillium pinophilum, were investigated on human breast cancer MCF-7 cells and cancer stem cells selected as mammospheres derived from MCF-7s.
MATERIALS AND METHODS: Stemness markers were analysed on isolated mammospheres showing positive expression of CD24, CD29, CD44, CD133, CD184 and CD338. Cell proliferation and apoptosis were analysed by flow cytometry and RT-PCR. Cell colony formation assays were performed to evaluate colony formation of mammospheres. RESULTS AND
CONCLUSION: OMF treatment affected both MCF-7 and mammosphere growth, inducing apoptosis. In addition, OMF strongly reduced stemness markers and survivin, hTERT and Nanog-1 gene expression. Growth of colonies in soft-agar was significantly affected by OMF treatment, too. Lastly, we tested ability of MCF-7 cells to form mammospheres after treatment with OMF or cisplatin, demonstrating that OMF treatment resulted in drastic reduction in number of mammospheres. These results introduce OMF as an effective molecule in suppressing breast cancer stem cells.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21951283      PMCID: PMC6495666          DOI: 10.1111/j.1365-2184.2011.00766.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  25 in total

Review 1.  Cancer stem cells.

Authors:  Craig T Jordan; Monica L Guzman; Mark Noble
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

2.  Cytostatic properties of a novel compound derived from Penicillium pinophilum: an in vitro study.

Authors:  Annalaura Stammati; Rosario Nicoletti; Salvatore De Stefano; Franco Zampaglioni; Flavia Zucco
Journal:  Altern Lab Anim       Date:  2002 Jan-Feb       Impact factor: 1.303

Review 3.  Clinical utility of telomerase in cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

Review 4.  Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Authors:  L Austin Doyle; Douglas D Ross
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

Review 5.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

6.  3-O-methylfunicone, a metabolite of Penicillium pinophilum, inhibits proliferation of human melanoma cells by causing G(2) + M arrest and inducing apoptosis.

Authors:  A Baroni; A De Luca; A De Filippis; M Petrazzuolo; L Manente; R Nicoletti; M A Tufano; E Buommino
Journal:  Cell Prolif       Date:  2009-05-22       Impact factor: 6.831

7.  Functional evidence that the self-renewal gene NANOG regulates human tumor development.

Authors:  Collene R Jeter; Mark Badeaux; Grace Choy; Dhyan Chandra; Lubna Patrawala; Can Liu; Tammy Calhoun-Davis; Holm Zaehres; George Q Daley; Dean G Tang
Journal:  Stem Cells       Date:  2009-05       Impact factor: 6.277

Review 8.  The increasing complexity of the cancer stem cell paradigm.

Authors:  Jeffrey M Rosen; Craig T Jordan
Journal:  Science       Date:  2009-06-26       Impact factor: 47.728

9.  3-O-methylfunicone, a secondary metabolite produced by Penicillium pinophilum, induces growth arrest and apoptosis in HeLa cells.

Authors:  E Buommino; R Nicoletti; G M Gaeta; M Orlando; M L Ciavatta; A Baroni; M A Tufano
Journal:  Cell Prolif       Date:  2004-12       Impact factor: 6.831

Review 10.  Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma.

Authors:  D E Costea; O Tsinkalovsky; O K Vintermyr; A C Johannessen; I C Mackenzie
Journal:  Oral Dis       Date:  2006-09       Impact factor: 3.511

View more
  8 in total

Review 1.  Recent progress in fungus-derived bioactive agents for targeting of signaling machinery in cancer cells.

Authors:  Xiukun Lin; Ammad Ahmad Farooqi; Muhammad Ismail
Journal:  Drug Des Devel Ther       Date:  2015-03-26       Impact factor: 4.162

Review 2.  Bioactive Compounds Produced by Strains of Penicillium and Talaromyces of Marine Origin.

Authors:  Rosario Nicoletti; Antonio Trincone
Journal:  Mar Drugs       Date:  2016-02-18       Impact factor: 5.118

Review 3.  Secondary Metabolites of Mangrove-Associated Strains of Talaromyces.

Authors:  Rosario Nicoletti; Maria Michela Salvatore; Anna Andolfi
Journal:  Mar Drugs       Date:  2018-01-06       Impact factor: 5.118

4.  Talarodiolide, a New 12-Membered Macrodiolide, and GC/MS Investigation of Culture Filtrate and Mycelial Extracts of Talaromyces pinophilus.

Authors:  Maria Michela Salvatore; Marina DellaGreca; Rosario Nicoletti; Francesco Salvatore; Francesco Vinale; Daniele Naviglio; Anna Andolfi
Journal:  Molecules       Date:  2018-04-19       Impact factor: 4.411

Review 5.  New Insights into Chemical and Biological Properties of Funicone-like Compounds.

Authors:  Maria Michela Salvatore; Marina DellaGreca; Anna Andolfi; Rosario Nicoletti
Journal:  Toxins (Basel)       Date:  2022-07-08       Impact factor: 5.075

Review 6.  Cancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer Treatment.

Authors:  Valéria B de Souza; André A Schenka
Journal:  Breast Cancer (Auckl)       Date:  2015-11-12

Review 7.  Anticancer and antifungal compounds from Aspergillus, Penicillium and other filamentous fungi.

Authors:  Tanja Thorskov Bladt; Jens Christian Frisvad; Peter Boldsen Knudsen; Thomas Ostenfeld Larsen
Journal:  Molecules       Date:  2013-09-13       Impact factor: 4.411

8.  Antiviral Property of the Fungal Metabolite 3-O-Methylfunicone in Bovine Herpesvirus 1 Infection.

Authors:  Filomena Fiorito; Claudia Cerracchio; Maria Michela Salvatore; Francesco Serra; Alessia Pucciarelli; Maria Grazia Amoroso; Rosario Nicoletti; Anna Andolfi
Journal:  Microorganisms       Date:  2022-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.